Indefinite Delivery Contract 36C24622D0015

Award Date 10/1/21
Last Date to Order 9/30/26
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 23 (VISN 23) awarded a single-award, $549,984.84 Indefinite Delivery Contract to Biomerieux Inc. for the provision of Vitek 2 and Vitek MS microbiology diagnostic testing supplies. The contract has a 5-year period of performance from October 1, 2023 to September 30, 2024. Under this IDC, the VA VISN 23 will issue firm-fixed-price delivery orders to Biomerieux's Emigration Canyon, Utah...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 awarded a single award Indefinite Delivery Contract to Biomerieux Inc. with a potential value of $7.4 million to provide identification, antimicrobial susceptibility testing, and matrix-assisted laser desorption/ionization clinical proteomics technology solutions. The original solicitation posted on January 18, 2023 sought these laboratory diagnostic testing equipment and services with a...
The U.S. Department of Veterans Affairs (VA) has awarded a single-award, indefinite delivery contract to Biomerieux Inc., a global leader in in vitro diagnostics, to provide bacterial identification and antibiotic susceptibility testing services to the VA's Veterans Integrated Service Network 2 (VISN 2). The contract, valued at a ceiling of $2,366,377.51, has an ultimate completion date of March 31, 2026 and does not utilize any set-aside designations. Under this IDC, Biomerieux Inc., through...
The federal contract IDV award is to Biomerieux Inc., a global leader in in vitro diagnostics, through its Biomerieux, Inc. division. The contract, awarded by the Veterans Integrated Service Network 6 (VISN 6), a civilian agency under the Department of Veterans Affairs, is for the delivery of VITEK microorganism identification and antibiotic susceptibility testing products and services. The contract does not have a set-aside designation, as Biomerieux is often the sole-source provider for its...
This single-award Indefinite Delivery Contract (IDC) was issued by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 21 (VISN 21) to Biomerieux Inc., a global diagnostics manufacturer, to provide an Automated Blood Culture System and associated reagents. The $2,000,000 contract has a period of performance through September 30, 2025. Biomerieux will deliver its proprietary VITEK, BioFire, and VIDAS platforms, consumables, and technical support services to support...
Biomerieux Inc. was awarded an indefinite delivery contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 to provide pathology identification, antimicrobial susceptibility testing, culture and procedure reporting services. The contract has a potential value of $600,000 and a period of performance through September 30, 2021. Two firm fixed price delivery orders have been issued against the contract to date, for a total of $458,182.71...
The Department of Veterans Affairs (VA) has awarded a single-award Indefinite Delivery Contract (IDC) to Biomerieux Inc. for VISN 8 Molecular Pathogen Detection. The contract, valued at $31,825,821.12, has an ultimate completion date of January 12, 2030, and was awarded on January 13, 2025. Under this IDC, Biomerieux Inc., through its Biomerieux, Inc. Division, will provide in-vitro diagnostic test panels, equipment, and related services to support molecular pathogen detection capabilities at...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded an indefinite delivery contract to Biomerieux Inc. to provide diagnostic testing equipment, supplies, and services in support of VISN 23's medical programs. The single award IDC has a potential value of $749,999.99 and orders may be placed through May 2024. Under the IDC, Biomerieux has received multiple firm fixed price delivery orders for its BioFire FilmArray systems and associated...
The Department of Veterans Affairs (VA) awarded an Indefinite Delivery Contract (IDC) to Biomerieux Inc., a global leader in in vitro diagnostics, to provide a blood culture system, including reagents, equipment, middleware, servers, and support services for the VA's Veterans Integrated Service Network 15 (VISN 15). The IDC, valued at up to $2,197,150.10, has a period of performance through July 31, 2025 and does not have a set-aside designation. Under this IDC, the VA has awarded multiple...
Biomerieux Inc., a global leader in in vitro diagnostics, was awarded a single-award Indefinite Delivery Contract (IDC) by the Department of Veterans Affairs' Veterans Integrated Service Network (VISN) 23. The contract, valued at $135,660.00, is for the maintenance and support of Biomerieux's specialized diagnostic equipment and platforms installed at VA healthcare facilities. The contract has an ultimate completion date of September 30, 2027, with the first two task orders valued at...
  • 36C24622D0015
    Indefinite Delivery Contract
  • 1
    Federal Contract Awards

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 awarded an indefinite-delivery contract to Biomerieux Inc. to provide diagnostic testing equipment and related services. Under the single award, firm fixed price IDC vehicle, Biomerieux will supply its VITEK 2 automated microbiology system and associated test kits. The potential value of the contract is $1,935,283.25 over its five year period of performance from October 2021 through September 2026.

A delivery order against the IDC awards Biomerieux a $265,776 task to supply VITEK 2 services through July 2023. Performance will take place in Eno Valley, North Carolina to assist VA medical centers in identifying and testing antibiotic susceptibilities of pathogens. The diagnostic testing supports the Agency's efforts to efficiently diagnose and treat veterans' healthcare needs. No set-asides were used in awarding under either the IDC or its related delivery order.

Generated 1/4/24, 11:40 PM